Vol 92, No 3 (2021)
Guidelines / Expert consensus
Published online: 2021-03-31

open access

Page views 1701
Article views/downloads 1099
Get Citation

Connect on Social Media

Connect on Social Media

The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practice

Artur Rogowski123, Bartosz Dybowski4, Edyta Wlazlak5, Wlodzimierz Baranowski6, Tomasz Rechberger7, Klaudia Stangel-Wojcikiewicz8, Magdalena E. Grzybowska9, Tomasz Kluz10, Elzbieta Narojczyk-Swiesciak11, Monika Szafarowska6, Zofia Rozpendowska5, Grzegorz Surkont5
Pubmed: 33844242
Ginekol Pol 2021;92(3):230-235.

Abstract

Objectives: The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the use of urodynamics (UDS) in the diagnostic process of patients with lower urinary tract symptoms (LUTS) based on the available literature, expert knowledge, and everyday practice. Material and methods: A review of the literature concerning the use of UDS in women, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, was conducted. Results: Urodynamic testing allows to make the urodynamic diagnosis which, nevertheless, remains to be the preliminary diagnosis. Medical history, physical examination, and detailed analysis of the previous test results (laboratory, imaging, endoscopic) need to be taken into consideration before making the final diagnosis. Urodynamic testing before surgical treatment of SUI is allowable, but the decision remains at the discretion of the physician. Urodynamic testing is not necessary before primary surgical treatment of uncomplicated SUI, but it has been demonstrated to optimize the therapeutic methods in complicated SUI. The significance of UDS in the diagnostic process of patients with overactive bladder symptoms, voiding dysfunction, and bladder outlet obstruction was discussed. Conclusions: Urodynamic testing is a vital element of the urogynecological diagnostic process. The scope of UDS should reflect the individual needs and symptoms of each patient and be based on the current guidelines, expert knowledge and experience of the physician, indications, and eligibility, as well as additional test results of the affected patients. Due to formal and legal requirements, PSGO, in this Guideline, wishes to emphasize the need for an individualized approach to both, test performance and result interpretation.

Article available in PDF format

View PDF Download PDF file